Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cidara Therapeutics Inc shares valued at $36,542 were sold by Ward Shane on Mar 11 ’25. At $21.96 per share, Ward Shane sold 1,664 shares. The insider’s holdings dropped to 14,674 shares worth approximately $0.34 million following the completion of this transaction.
Also, Tari Leslie sold 1,773 shares, netting a total of over 38,940 in proceeds. Following the sale of shares at $21.96 each, the insider now holds 16,215 shares.
Before that, Sandison Taylor had sold 924 shares from its account. In a trade valued at $10,752, the Chief Medical Officer traded Cidara Therapeutics Inc shares for $11.64 each. Upon closing the transaction, the insider’s holdings decreased to 924 shares, worth approximately $0.53 million.
As published in their initiating research note from Citizens JMP on March 12, 2025, Cidara Therapeutics Inc [CDTX] has been a Mkt outperform and the price target has been revised to $46. As of December 13, 2024, RBC Capital Mkts has initiated its “an Outperform” rating for CDTX. Earlier on November 08, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for CDTX stock.
Analyzing CDTX Stock Performance
During the last five days, there has been a surge of approximately 3.31%. Over the course of the year, Cidara Therapeutics Inc shares have dropped approximately -14.06%. Shares of the company reached a 52-week high of $28.42 on 01/02/25 and a 52-week low of $17.17 on 01/30/25. A 50-day SMA is recorded $21.95, while a 200-day SMA reached $16.12.
Support And Resistance Levels for Cidara Therapeutics Inc (CDTX)
According to the 24-hour chart, there is a support level at 22.42, which, if violated, would cause prices to drop to 21.75. In the upper region, resistance lies at 23.63. The next price resistance is at 24.17. RSI (Relative Strength Index) is 53.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.11, which suggests the price will decrease in the coming days. Percent R is at 47.58%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Cidara Therapeutics Inc (CDTX)?
On August 14, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and upgraded coverage with a $24.
